Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer

INTRODUCTION: Pharmacogenomics is about selecting the “right drug in the right amount for the right patient.” In metastatic colorectal cancer, germline pharmacogenomics testing presents a unique opportunity to improve outcomes, since the genes dihydropyrimidine dehydrogenase and UDP-glucuronosyltran...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi, Pashtoon Murtaza, Koep, Tyler, Schnettler, Erica, Shahjehan, Faisal, Kamatham, Vaishnavi, Baldeo, Candice, Hughes, Caren L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753511/
https://www.ncbi.nlm.nih.gov/pubmed/31533552
http://dx.doi.org/10.1177/1533033819873924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753511/
https://www.ncbi.nlm.nih.gov/pubmed/31533552
http://dx.doi.org/10.1177/1533033819873924

Ejemplares similares